A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
Published 2011 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
A Candidate HIV/AIDS Vaccine (MVA-B) Lacking Vaccinia Virus Gene C6L Enhances Memory HIV-1-Specific T-Cell Responses
Authors
Keywords
-
Journal
PLoS One
Volume 6, Issue 8, Pages e24244
Publisher
Public Library of Science (PLoS)
Online
2011-09-01
DOI
10.1371/journal.pone.0024244
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Attenuated poxvirus vectors MVA and NYVAC as promising vaccine cadidates against HIV/AIDS
- (2014) Mariano Esteban Human vaccines & immunotherapeutics
- Dissociation between Epitope Hierarchy and Immunoprevalence in CD8 Responses to Vaccinia Virus Western Reserve
- (2014) C. Oseroff et al. JOURNAL OF IMMUNOLOGY
- Profound early control of highly pathogenic SIV by an effector memory T-cell vaccine
- (2011) Scott G. Hansen et al. NATURE
- Dendritic Cells Exposed to MVA-Based HIV-1 Vaccine Induce Highly Functional HIV-1-Specific CD8+ T Cell Responses in HIV-1-Infected Individuals
- (2011) Núria Climent et al. PLoS One
- Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching
- (2011) Kristina E. Rehm et al. VACCINE
- Strong HIV-Specific CD4+ and CD8+ T-Lymphocyte Proliferative Responses in Healthy Individuals Immunized with an HIV-1 DNA Vaccine and Boosted with Recombinant Modified Vaccinia Virus Ankara Expressing HIV-1 Genes
- (2010) S. Aboud et al. Clinical and Vaccine Immunology
- Selective Induction of Host Genes by MVA-B, a Candidate Vaccine against HIV/AIDS
- (2010) S. Guerra et al. JOURNAL OF VIROLOGY
- The Vaccinia Virus Complement Control Protein Modulates Adaptive Immune Responses during Infection
- (2010) N. M. Girgis et al. JOURNAL OF VIROLOGY
- Phase 1 Safety and Immunogenicity Evaluation of ADMVA, a Multigenic, Modified Vaccinia Ankara-HIV-1 B'/C Candidate Vaccine
- (2010) Sandhya Vasan et al. PLoS One
- Insertion of Vaccinia Virus C7L Host Range Gene into NYVAC-B Genome Potentiates Immune Responses against HIV-1 Antigens
- (2010) José Luis Nájera et al. PLoS One
- Immunogenic Profiling in Mice of a HIV/AIDS Vaccine Candidate (MVA-B) Expressing Four HIV-1 Antigens and Potentiation by Specific Gene Deletions
- (2010) Juan García-Arriaza et al. PLoS One
- Phase I Safety and Immunogenicity Evaluation of MVA-CMDR, a Multigenic, Recombinant Modified Vaccinia Ankara-HIV-1 Vaccine Candidate
- (2010) Jeffrey R. Currier et al. PLoS One
- A poxvirus Bcl-2-like gene family involved in regulation of host immune response: sequence similarity and evolutionary history
- (2010) José M González et al. Virology Journal
- A Phase 1 Study to Evaluate the Safety and Immunogenicity of a Recombinant HIV Type 1 Subtype C-Modified Vaccinia Ankara Virus Vaccine Candidate in Indian Volunteers
- (2009) Vadakkuppatu Devasenapathi Ramanathan et al. AIDS RESEARCH AND HUMAN RETROVIRUSES
- The Interferon System and Vaccinia Virus Evasion Mechanisms
- (2009) Beatriz Perdiguero et al. JOURNAL OF INTERFERON AND CYTOKINE RESEARCH
- Analysis of Vaccinia Virus−Host Protein−Protein Interactions: Validations of Yeast Two-Hybrid Screenings
- (2009) Leiliang Zhang et al. JOURNAL OF PROTEOME RESEARCH
- Vaccine-Induced Cellular Responses Control Simian Immunodeficiency Virus Replication after Heterologous Challenge
- (2009) N. A. Wilson et al. JOURNAL OF VIROLOGY
- Effector memory T cell responses are associated with protection of rhesus monkeys from mucosal simian immunodeficiency virus challenge
- (2009) Scott G Hansen et al. NATURE MEDICINE
- Vaccination with ALVAC and AIDSVAX to Prevent HIV-1 Infection in Thailand
- (2009) Supachai Rerks-Ngarm et al. NEW ENGLAND JOURNAL OF MEDICINE
- Structural Basis for Targeting of Human RNA Helicase DDX3 by Poxvirus Protein K7
- (2009) Shun-ichiro Oda et al. STRUCTURE
- Multimeric soluble CD40 ligand (sCD40L) efficiently enhances HIV specific cellular immune responses during DNA prime and boost with attenuated poxvirus vectors MVA and NYVAC expressing HIV antigens
- (2009) Carmen E. Gómez et al. VACCINE
- Innate Immune Sensing of Modified Vaccinia Virus Ankara (MVA) Is Mediated by TLR2-TLR6, MDA-5 and the NALP3 Inflammasome
- (2009) Julie Delaloye et al. PLoS Pathogens
- The Poxvirus Vectors MVA and NYVAC as Gene Delivery Systems for Vaccination Against Infectious Diseases and Cancer
- (2008) Carmen Gomez et al. CURRENT GENE THERAPY
- Viral targeting of DEAD box protein 3 reveals its role in TBK1/IKKɛ-mediated IRF activation
- (2008) Martina Schröder et al. EMBO JOURNAL
- An HIV-1 clade C DNA prime, NYVAC boost vaccine regimen induces reliable, polyfunctional, and long-lasting T cell responses
- (2008) Alexandre Harari et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Broad Immunogenicity of a Multigene, Multiclade HIV‐1 DNA Vaccine Boosted with Heterologous HIV‐1 Recombinant Modified Vaccinia Virus Ankara
- (2008) Eric Sandström et al. JOURNAL OF INFECTIOUS DISEASES
- Poxvirus K7 Protein Adopts a Bcl-2 Fold: Biochemical Mapping of Its Interactions with Human DEAD Box RNA Helicase DDX3
- (2008) Arnout P. Kalverda et al. JOURNAL OF MOLECULAR BIOLOGY
- Differential CD4+ versus CD8+ T-Cell Responses Elicited by Different Poxvirus-Based Human Immunodeficiency Virus Type 1 Vaccine Candidates Provide Comparable Efficacies in Primates
- (2008) P. Mooij et al. JOURNAL OF VIROLOGY
- Recombination-Mediated Genetic Engineering of a Bacterial Artificial Chromosome Clone of Modified Vaccinia virus Ankara (MVA)
- (2008) Matthew G. Cottingham et al. PLoS One
- Inhibition of IκB Kinase by Vaccinia Virus Virulence Factor B14
- (2008) Ron A.-J. Chen et al. PLoS Pathogens
- Kinetic analysis of a complete poxvirus transcriptome reveals an immediate-early class of genes
- (2008) E. Assarsson et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- EV01: A phase I trial in healthy HIV negative volunteers to evaluate a clade C HIV vaccine, NYVAC-C undertaken by the EuroVacc Consortium
- (2008) Pierre-Alexandre Bart et al. VACCINE
- EV02: A Phase I trial to compare the safety and immunogenicity of HIV DNA-C prime-NYVAC-C boost to NYVAC-C alone
- (2008) Sheena McCormack et al. VACCINE
- Vaccinia Virus Proteins A52 and B14 Share a Bcl-2–Like Fold but Have Evolved to Inhibit NF-κB rather than Apoptosis
- (2008) Stephen C. Graham et al. PLoS Pathogens
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search